In response to member company concerns about the regulatory interpretation of recent laws and regulations over the past six months, the US-China Business Council (USCBC) continues its advocacy initiatives and its operating environment analyses and best practices for member companies in the United States and China.
A series of recent hospital reforms by the Chinese government are designed to standardize pricing and encourage investment in the medical system. Moves from medical and registration fees to a medical service fee and a new focus on establishing a system of family doctors could bring China’s public hospitals in line with many private hospitals and standard international practices.
Four new policies under development may address a variety of lingering regulatory hurdles for foreign drug and device companies in China.
During the eighth Strategic & Economic Dialogue which concluded early this week in Beijing — the final round for the Obama administration, China said it would offer a revised Bilateral Investment Treaty (BIT) negative list next week in Washington, DC, according to statements made by Vice Premier Wang Yang and Treasury Secretary Jacob Lew.